Products
Online Inquiry
IM21.7c
Cat. No.:
OB0626WX-3752
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR and HPLC.
Size:
Add to basket
Product Overview
Description:
IM21.7c is an amphiphilic cationic lipid engineered to serve as a structural assembly core for nucleic acid-loaded lipid nanoparticles. Upon systemic administration, the unique molecular architecture and charge distribution of this lipid matrix alter typical biodistribution dynamics, causing self-assembled delivery vehicles to bypass primary hepatic clearance and accumulate selectively within respiratory and splenic tissue compartments.
Synonyms:
1-butyl-3-[1-(3,7-dimethyloctyl)-6-octadecyltetracosyl]-1H-imidazolium, monochloride; LipidBrick IM21.7c; IM217c; 2416939-42-7; 1-butyl-3-(2,6-dimethyl-14-octadecyldotriacontan-9-yl)-1H-imidazol-3-ium chloride; 3-butyl-1-(2,6-dimethyl-14-octadecyldotriacontan-9-yl)-1H-imidazol-3-ium chloride
CAS No.:
2416939-42-7
Compound CID:
146520984
Formula:
C59H117N2 • Cl
Formula Weight:
890
Specification
Solubility in DMSO:
0.1-1 mg/mL
Solubility in Ethanol:
1-10 mg/mL
Solubility in Other Solvents:
PBS: 0.1-1 mg/mL
Storage:
Storage at -20°C.
Applications:
IM21.7c is used in lipid-based delivery research as a functional lipid material for investigating nanoparticle formation, lipid organization, and formulation optimization. It supports studies focused on lipid composition screening, characterization of delivery systems, and evaluation of lipid-dependent formulation properties.